Genetically engineered mice deficient for CD8+ cytotoxic T-lymphocyte (CTLs), CD4+ Th1 helper T-cells, or natural killer (NK) cells components of the immune system, show an increased tumor incidence [51,52]. This evidence concerns the gene CD4 and neoplasm.